Although infants with acute lymphoblastic leukemia (ALL) and a germline MLL gene have a better prognosis than comparable infants with a rearranged MLL gene, their optimal therapy is controversial. In 2 consecutive studies, conducted between 1996 and 2002, we treated 22 cases of infant ALL with germline MLL using chemotherapy alone. The 5-year event-free survival rate was 95.5% with a 95% confidence interval of 86.9 to 100%. All 21 infants with precursor B-cell ALL have been in first complete remission for 3.5 to 8.8 years. Most treatment-related toxicities were predictable and well tolerated, and neither secondary malignancies nor physical growth impairments have been observed. These results indicate that chemotherapy of the type described here is both safe and highly effective against infant precursor B-cell ALL with MLL in the germline configuration.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1182/blood-2005-11-4728 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Targeting Menin in Acute Myeloid Leukemia: Therapeutic Advances and Future Directions.
Cancers (Basel)
November 2024
Department of Oncology, Karmanos Cancer Center, School of Medicine, Wayne State University, Detroit, MI 48201, USA.
Germline mutations in the gene encoding menin protein cause multiple endocrine neoplasia type 1 (MEN1) syndrome. Recent evidence suggests that inhibiting the interaction of menin with its crucial oncogenic protein partners represents a promising therapeutic strategy to AML. Menin plays a critical role in lysine methyltransferase 2A ()-gene-rearranged and -m acute leukemias, both associated with adverse outcomes with current standard therapies, especially in the relapsed/refractory setting.
View Article and Find Full Text PDFA high proportion of germline variants in pediatric chronic myeloid leukemia.
Mol Cancer
September 2024
Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Loschgestrasse 15, 91054, Erlangen, Germany.
Article Synopsis
- * Research on pediatric CML revealed that about 60% of young patients have germline variants, primarily in genes like ASXL1, NOTCH1, KDM6B, and TET2, while adult patients show fewer such variants.
- * This study suggests that these germline variants may work together with the BCR::ABL1 oncogene to increase the risk of developing CML in children, potentially triggering the disease at an earlier age.
Unraveling the germline inheritance of the F556V gene mutation in familial thrombocythemia: a comprehensive analysis of 11 family members and potential implications for surveillance.
Haematologica
September 2024
Hematology Oncology Center, Munich, Germany; LMU University of Munich, Munich.
Not available.
View Article and Find Full Text PDFClinically Defined Mutations in Alter Its Tumor-suppressive Function Through Increased Menin Turnover.
Cancer Res Commun
July 2023
Division of Gastroenterology and Hepatology, Department of Medicine, University of Arizona College of Medicine, Tucson, Arizona.
Article Synopsis
- Loss of menin, a tumor suppressor protein, is critical in the development of neuroendocrine tumors, especially in hormone-expressing tissues like gastrinomas.
- The study investigated how specific mutations in the menin gene (R516fs, E235K) and a variant (A541T) impact its stability and function, using various cell lines and mouse models.
- Results showed that these mutations and variant lead to instability and loss of menin function, enhancing tumor growth and gastrin expression; however, treatment with MI-503 helped stabilize menin and reduce tumor symptoms in mice.
Genetic Factors in Familial Manifestation of Primary Mediastinal Large B-Cell Lymphoma over Two Generations.
Pathobiology
December 2023
Department of Oncology, University Hospital Basel, Basel, Switzerland.
Introduction: Primary mediastinal large B-cell lymphoma (PMBL) is a rarely occurring lymphoid malignancy which typically affects young adults and presents itself as an anterior mediastinal mass. Gene expression profiling as well as somatic genetic analysis revealed that it is closely related to classical Hodgkin lymphoma, whereas morphologically, it tends to resemble diffuse large B-cell lymphoma. Familial clustering of PMBL is rare - only two reports have been published to date.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!